FDAnews Drug Daily Bulletin

CALLISTO ESTABLISHES INTELLECTUAL PROPERTY DEPARTMENT TO EXPAND NEW DRUG PIPELINE

Dec. 12, 2005
A A

Callisto Pharmaceuticals, Inc. (AMEX:KAL) (FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, today announced the formation of a Department of Intellectual Property to spearhead growth of the Company's pipeline of new drug candidates, while broadening protection of its intellectual property portfolio through creation of multiple patents around broad classes of new drugs, as well as narrowly-focused claims on specific compounds.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20051208005754&newsLang=en)